Prestorage leukocyte reduction with in-line filtration of whole blood: Evaluation of red cells and plasma storage

Vox Sanguinis

Volumn 73, Issue 1, 1997, Pages 28-35

  Rapaille, André ^a   Moore, Glenn ^b   Siquet, Jean ^a   Flament, Jocelyne ^b   Sondag Thull, Danièle ^a,c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Baxter R and D Europe   (Belgium)

^c Blood Transfusion Centre   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOPEPTIDE A; FRESH FROZEN PLASMA;

ARTICLE; BLOOD COMPONENT; BLOOD STORAGE; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; FILTRATION; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL;

EID: 0030857585     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7310028.x     Document Type: Article

References (38)

1. Murphy MF, Metealfe P, Thomas H, Eve E, Ord J. Lister LA, Waters AH: Use of leukocyte-poor blood components and HLA-matched platelet donors to prevent HLA-alloimmunization. Br J Haematol 1986;62:529-534.
2. Sniecinski I, O'Donnell MR, Mowicki B, Hill LR: Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 1988:71:1402-1407.
3. van Marwijk Kooy M, van Prooijen HC, Mocs M, Bosma-Stants I, Akkerman JWN: Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmuization: A prospective, randomized trial Blood 1991;77:201-205.
4. Gilbert GL, Hayes K, Hudson IL, James J. et al: Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Lancet 1989;1:1228-1231.
5. de Graan-Hentzen YCE, Gratama JW, Mudde GC, Vcrdonck LF, Houbiers JGA, Brand A, Se bens FW, van Loon AM, The TH, Willemze R, de Gast GC: Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 1989;29:757-760.
6. Eisenfeld L, Silver H, Mac Laughlin J, Klevjer-Anderson P, Mayo D, Anderson J, Herson V, Krause P, Savidakis J, Lazar A, Rosenkrantz T, Pisciotto P: Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of White cells from blood Transfusion 1992;32:205-209.
7. van Prooijen HC, Visser JJ, van Oostendorp WR, de Gast GC, Verdonck LF: Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. Br J Haematol 1994;87:144-147.
8. Okochi K, Sato H: Transmission of adult T-cell leukemia virus (HTLV-1) through blood transfusion and us prevention AIDS 1986;2:515-5161.
9. Masse M, Andreu G, Babault C, Beaujean F, Bidet ML, Boudart D, Calot JP, Cotte C, Follca G, Gerota J, Hau F, Hurel C, Legrand E, Marchesseau B, Nasr O, Robert F, Royer D, Schooncman F, Tardivel R, Vidal M: A multicenter study on the efficiency of white cell reduction by filtration of red cells. Transfusion 1991;31:792-797.
10. Rebulla P, Porretti L, Bertolini F, Marangoni F, Prati D, Smacchia C, Pappalettera M, Parravicini A, Sirchia G: White cell-reduced red cells prepared by filtration: A critical evaluation of current filters and methods for counting residual white cells. Transfusion 1993;33:128-133.
11. Brecher ME, Pineda AA, Torloni AS, Harbaugh CA, Emery RL, Moore SB, Carmen R, Nelson E: Prestorage leukocyte depletion: Effect on leukocyte and platelet metabolites, erthrocyte lysis, metabolism, and in vivo survival. Semin Heamtol 1991;28(suppl 5):3-9.
12. Humbert JR, Fermin CD, Winsor EL: Early damage to granulocytes during storage. Semin Hematol 1991;28(Suppl 5): 10-13.
13. Frewin DB, Dyer SM, Haylock DN, Bates IR, Davis KG, Beal RW: A comparative study of the effect of three methods of leukocyte removal on plasma histamine levels in stored human blood. Semin Hematol 1991:28(Suppl 5):18-21.
14. Davey RJ, Carmen RA, Simon TL, Nelson EJ, Leng BS, Chong C, Gareez RB, Sohmer PR: Preparation of white cell-depleted red cells for 42-day storage using an integral in-line filter Transfusion 1989;29:496-499.
15. Rogers SE, Edmondson D, Goodrick MJ, Standen GR, Franck V, Reppucct A, Pamphilon DH: Prestorage while cell reduction in salme-adenine-glucose-inannitol red cells by use of an integral filter: Evaluation of storages values and in vivo recovery Transfusion 1995;35:727-733.
16. Anguc M, Chatelain P, Fiabane S, Domy M, Guignier F, Richaud P: Viabilité des globules rouges humains conservés pendant 35 jours après déplétion en leucocytes (étude in vitro). Rev Fr Transfus Hémobiol 1989;32:27-36.
17. 10, prestorage leukocyte depletion on red cell storage and metabolism. Br J Haematol 1994;87:363-368.
18. Riggert J, Simson G, Dittmann J, Köhler M: Prestorage leukocyte depletion with in-line filtration of whole blood component leukocyte depletion. Vox Sang 1995;69:201-205.
19. Riedner C, Heim MU, Mempel W, Wilmanns W: Possibility to improve preservation of whole blood by leukocyte-depletion before storage. Vox Sang 1990;59:78-82.
20. Masse M, Naegelen C, Pelligrini N, Segier JM, Marpaux N, Beaujean F: Validation of a simple method to count very low white cell concentrations in filtered red cells or platelets Transfusion 1992;32:565-571.
21. Ferenz A, Bacso M: Quantitative determination of serum and plasma haemoglobin using phenothiazines. Clin Chim Acta 1983;134:103-106.
22. Clauss A: Gerinnungsphysiologische Sehnell-methode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-247.
23. Wright P: Adjusted p-values for simultaneous inferences Biometrics 1992:48:1005-1013.
24. Council of Europe: Guide to Preparation. Use and Quality Assurance of Blood Components. Strasbourg. Council of Europe Publishing, 1995,p 184.
25. Högman CF, Eriksson L, Gong J, Högman AB, Payrat JM: Shall red cell units stand upright, lie flat or be mixed during storage? In vitro studies of red cells collectod m 0.5 CPD and stored in RAS2 (Erythrosol) Transfus Sci 1995;16:193-199
26. Glaser A, Erpenbeek T, Böck M, Heim M, Mempel W: Effectiveness of white cell reduction by filtration with respect to blood storage time. Transfusion 1993;33:536-537
27. Williamson LM, Wimperis JZ, Williamson P, Copplestopne JA, Gooi HC, Morgerstren GR, Norfolk DR Bedstde filtration of blood products in the prevention of HLA alloimmunization A prospective randomized study Blood 1994;83:3028-3035.
28. Federowiez I, Barrett BB, Andersen JW, Urashima M, Popovsky MA, Anderson KC: Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996;36:21-28
29. Blajchman MA, Bardossy L, Carmen RA, Goldman M, Heddle NM, Singal DP: An animal model of allogeneic donor platelet refractoriness: The effect of the time of leukodepletion Blood 1992;79:1371-1375.
30. Pietersz RM, Steneker I, Reesink HW: Prestorage leukocyte depletion of blood products in a closed system. Transfus Med Rev 1993;7:17-24.
31. Bontadini A, Fruct F, Tazzari PL, Lollini PL, Conte R: Comparative analysis of six different white cell-reduction filters for packed red cells. Transfusion 1994;34:531-535.
32. Golman M, Delage G. The role of leukodepletion in the control of transfusion-transmitted disease. Transfus Med Rev 1995;9:9-19.
33. Saarinen UM, Koskimies S, Myllylä G: Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer. Vox Sang 1993;65:286-292.
34. Beaujean F, Segier JM, le Forestier C, Duaderi N: Leukocyte depletion of red cell concentrates by filtration: Influence of blood product temperature. Vox Sang 1992;62:242-243.
35. Carlebjörk G, Blombäck M, Akerblom O: Improvement of plasma quality as raw material for factor VIII:C concentrates. Vox Sang 1983;45: 233-242.
36. Simon T: Changes in plasma coagulation factors during Mood storage Plasma Ther Transfus Technol 1988;9:309-315.
37. Rock G: What are the critical factors in the production and quality control of frozen plasma intended for direct transfusion or for fractionation to provide medically needed labile coagulation factors? Vox Sang 1983;44:246-259.
38. Pflugshaupt R, Kurt G, FPA content - A criterion of quality for plasma as factor VIII source. Vox Sang 1983;45:224-232.